Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease

Clinica Chimica Acta

Volumn 360, Issue 1-2, 2005, Pages 178-186

  Ndrepepa, Gjin ^a   Braun, Siegmund ^a   Von Beckerath, Nicolas ^a   Mehilli, Julinda ^a   Gorchakova, Olga ^a   Vogt, Wolfgang ^a   Schömig, Albert ^a,b   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coronary artery disease; Oxidized low density lipoproteins; Statins

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATTENUATION; CIRCULATION; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; OXIDATION; PATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

AGED; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; DRUG EVALUATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 24044547073     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.04.032     Document Type: Article

References (35)

1. J.R. Hessler, D.W. Morel, L.J. Lewis, and G.M. Chisolm Lipoprotein oxidation and lipoprotein-induced cytotoxicity Arteriosclerosis 3 1983 215 222
2. D. Steinberg, and A. Lewis Conner memorial lecture. Oxidative modification of LDL and atherogenesis Circulation 95 1997 1062 1071
3. C.A. Hamilton Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis Pharmacol Ther 74 1997 55 72
4. J.L. Witztum, and D. Steinberg The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 11 2001 93 102
5. H. Itabe Oxidized low-density lipoproteins: what is understood and what remains to be clarified Biol Pharm Bull 26 2003 1 9
6. S. Yla-Herttuala, W. Palinski, and M.E. Rosenfeld Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J Clin Invest 84 1989 1086 1095
7. W. Palinski, M.E. Rosenfeld, and S. Yla-Herttuala Low density lipoprotein undergoes oxidative modification in vivo Proc Natl Acad Sci U S A 86 1989 1372 1376
8. P. Holvoet, J.M. Stassen, J. Van Cleemput, D. Collen, and J. Vanhaecke Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease Arterioscler Thromb Vasc Biol 18 1998 100 107
9. S. Toshima, A. Hasegawa, and M. Kurabayashi Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease Arterioscler Thromb Vasc Biol 20 2000 2243 2247
10. T. Vasankari, M. Ahotupa, and J. Toikka Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy Atherosclerosis 155 2001 403 412
11. J. Hulthe, and B. Fagerberg Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study) Arterioscler Thromb Vasc Biol 22 2002 1162 1167
12. P. Holvoet, G. Theilmeier, B. Shivalkar, W. Flameng, and D. Collen LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs Arterioscler Thromb Vasc Biol 18 1998 415 422
13. K. Nishi, H. Itabe, and M. Uno Oxidized LDL in carotid plaques and plasma associates with plaque instability Arterioscler Thromb Vasc Biol 22 2002 1649 1654
14. S. Ehara, M. Ueda, and T. Naruko Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 2001 1955 1960
15. S. Tsimikas, C. Bergmark, and R.W. Beyer Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes J Am Coll Cardiol 41 2003 360 370
16. T.J. Anderson, I.T. Meredith, and F. Charbonneau Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans Circulation 93 1996 1647 1650
17. S. Sasaki, N. Kuwahara, and K. Kunitomo Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia Am J Cardiol 89 2002 386 389
18. R.S. Rosenson, D. Wolff, and C.C. Tangney Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia Clin Sci (Lond) 106 2004 215 217
19. M. Crisby, G. Nordin-Fredriksson, P.K. Shah, J. Yano, J. Zhu, and J. Nilsson Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926 933
20. World Health Organization Diabetes mellitus WHO Tech Rep Ser 727 1985 1 104
21. P. Holvoet, J. Donck, and M. Landeloos Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure Thromb Haemost 76 1996 663 666
22. L.M. Giroux, J. Davignon, and M. Naruszewicz Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages Biochim Biophys Acta 1165 1993 335 338
23. D. Ferro, S. Parrotto, S. Basili, C. Alessandri, and F. Violi Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia J Am Coll Cardiol 36 2000 427 431
24. U. Laufs, V. La Fata, J. Plutzky, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
25. W.H. Kaesemeyer, R.B. Caldwell, J. Huang, and R.W. Caldwell Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions J Am Coll Cardiol 33 1999 234 241
26. A. Undas, K.E. Brummel, J. Musial, K.G. Mann, and A. Szczeklik Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation Circulation 103 2001 2248 2253
27. Y. Rikitake, S. Kawashima, and S. Takeshita Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits Atherosclerosis 154 2001 87 96
28. M. Yasuhara, K. Suzumura, and K. Tanaka Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits Biol Pharm Bull 23 2000 570 574
29. U. Rueckschloss, J. Galle, J. Holtz, H.R. Zerkowski, and H. Morawietz Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy Circulation 104 2001 1767 1772
30. P. Holvoet, A. Mertens, and P. Verhamme Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Arterioscler Thromb Vasc Biol 21 2001 844 848
31. G.P. Rossi, M. Cesari, and R. De Toni Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients Circulation 108 2003 2467 2472
32. Y. Shoenfeld, R. Wu, L.D. Dearing, and E. Matsuura Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? Circulation 110 2004 2552 2558
33. P. Holvoet, T.B. Harris, and R.P. Tracy Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study Arterioscler Thromb Vasc Biol 23 2003 1444 1448
34. P. Holvoet, J. Vanhaecke, S. Janssens, F. Van de Werf, and D. Collen Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease Circulation 98 1998 1487 1494
35. P. Holvoet, and D. Collen Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis Atherosclerosis 137 Suppl 1998 S33 S38